| 000 | 01393 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513003216.0 | ||
| 264 | 0 | _c19801027 | |
| 008 | 198010s 0 0 eng d | ||
| 022 | _a0003-9780 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRengo, F | |
| 245 | 0 | 0 |
_aLong term comparative study of guanfacine and alpha-methyldopa in essential hypertension. _h[electronic resource] |
| 260 |
_bArchives internationales de pharmacodynamie et de therapie _cApr 1980 |
||
| 300 |
_a281-91 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBlood Pressure |
| 650 | 0 | 4 | _aBody Height |
| 650 | 0 | 4 | _aBody Surface Area |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGuanfacine |
| 650 | 0 | 4 |
_aGuanidines _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethyldopa _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPhenylacetates _xtherapeutic use |
| 700 | 1 | _aRicciardelli, B | |
| 700 | 1 | _aVolpe, M | |
| 700 | 1 | _aTrimarco, B | |
| 700 | 1 | _aSaccà, L | |
| 700 | 1 | _aCondorelli, M | |
| 773 | 0 |
_tArchives internationales de pharmacodynamie et de therapie _gvol. 244 _gno. 2 _gp. 281-91 |
|
| 999 |
_c6996293 _d6996293 |
||